Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

MEREO BIOPHARMA GROUP PLC

(MREO)
  Report
Delayed Nasdaq  -  04:00 2022-09-23 pm EDT
0.8417 USD   -3.38%
09/23Rubric Capital Management Issues Open Letter to Mereo BioPharma Shareholders
CI
09/22European ADRs Move Lower in Thursday Trading
MT
09/21European ADRs Move Lower in Wednesday Trading
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Mereo BioPharma : Needham Starts Mereo BioPharma Group at Buy With $10 Price Target

04/05/2021 | 06:55am EDT


© MT Newswires 2021
All news about MEREO BIOPHARMA GROUP PLC
09/23Rubric Capital Management Issues Open Letter to Mereo BioPharma Shareholders
CI
09/22European ADRs Move Lower in Thursday Trading
MT
09/21European ADRs Move Lower in Wednesday Trading
MT
09/14European ADRs Move Slightly Higher in Wednesday Trading
MT
09/14Rubric Capital Management Issues Open Letter to Mereo BioPharma Shareholders
BU
09/14Rubric Capital Management LP Issues a Letter to the Shareholders of Mereo BioPharma Gro..
CI
09/13European ADRs Drop Sharply in Tuesday Trading
MT
09/12Ultragenyx and Mereo BioPharma to Present Setrusumab Data Update at ASBMR
AQ
09/12Mereo BioPharma Reports Clinical Update and Interim Biomarker Analysis Presented at ESM..
AQ
09/12Mereo Biopharma Group plc Reports Clinical Update and Interim Biomarker Analysis Presen..
CI
More news
Analyst Recommendations on MEREO BIOPHARMA GROUP PLC
More recommendations
Financials
Sales 2022 - - -
Net income 2022 -41,6 M -45,5 M -45,5 M
Net cash 2022 32,5 M 35,5 M 35,5 M
P/E ratio 2022 -10,6x
Yield 2022 -
Capitalization 83,7 M 91,5 M 91,5 M
EV / Sales 2022 -
EV / Sales 2023 8,31x
Nbr of Employees 49
Free-Float 51,6%
Chart MEREO BIOPHARMA GROUP PLC
Duration : Period :
Mereo BioPharma Group plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEREO BIOPHARMA GROUP PLC
Short TermMid-TermLong Term
TrendsBearishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 76,99 GBX
Average target price 523,80 GBX
Spread / Average Target 580%
EPS Revisions
Managers and Directors
Denise Vera Scots-Knight Chief Executive Officer & Director
Christine Fox Chief Financial Officer
Michael S. Wyzga Chairman
John A. Lewicki Chief Scientific Officer
Suba Krishnan Senior Vice President-Clinical Development
Sector and Competitors
1st jan.Capi. (M$)
MEREO BIOPHARMA GROUP PLC-47.39%91
GILEAD SCIENCES, INC.-13.43%78 787
REGENERON PHARMACEUTICALS, INC.10.42%74 550
VERTEX PHARMACEUTICALS29.08%72 693
BIONTECH SE-50.21%31 192
WUXI APPTEC CO., LTD.-41.46%28 154